Search

Bahar Alawi Craigo

Examiner (ID: 2811, Phone: (571)270-1326 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1759, 1673, 1699, 1623, 4131
Total Applications
904
Issued Applications
359
Pending Applications
130
Abandoned Applications
452

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17385676 [patent_doc_number] => 20220033528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => Production of Crystalline Cellulose [patent_app_type] => utility [patent_app_number] => 17/450805 [patent_app_country] => US [patent_app_date] => 2021-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8585 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17450805 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/450805
Production of Crystalline Cellulose Oct 12, 2021 Pending
Array ( [id] => 18815983 [patent_doc_number] => 20230390322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-07 [patent_title] => HIGH CONCENTRATION METHYLCOBALAMIN OR COMBINATION OF METHYL- AND HYDROXY-COBALAMIN FOR THE TREATMENT OF COBALAMIN C DEFICIENCY DISORDERS [patent_app_type] => utility [patent_app_number] => 18/032132 [patent_app_country] => US [patent_app_date] => 2021-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15380 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032132 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/032132
HIGH CONCENTRATION METHYLCOBALAMIN OR COMBINATION OF METHYL- AND HYDROXY-COBALAMIN FOR THE TREATMENT OF COBALAMIN C DEFICIENCY DISORDERS Oct 11, 2021 Pending
Array ( [id] => 17519269 [patent_doc_number] => 20220105117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => COMPOSITIONS COMPRISING NICOTINAMIDE RIBOSIDE AND A UROLITHIN [patent_app_type] => utility [patent_app_number] => 17/497392 [patent_app_country] => US [patent_app_date] => 2021-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11015 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17497392 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/497392
Compositions comprising nicotinamide riboside and a urolithin Oct 7, 2021 Issued
Array ( [id] => 19368312 [patent_doc_number] => 12060382 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-08-13 [patent_title] => Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 b-L-ribofuranosyl)-1H-benzimidazole [patent_app_type] => utility [patent_app_number] => 17/481980 [patent_app_country] => US [patent_app_date] => 2021-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 6644 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17481980 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/481980
Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 b-L-ribofuranosyl)-1H-benzimidazole Sep 21, 2021 Issued
Array ( [id] => 18752404 [patent_doc_number] => 20230355646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => AUTOPHAGY ACTIVATOR [patent_app_type] => utility [patent_app_number] => 18/026057 [patent_app_country] => US [patent_app_date] => 2021-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16821 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18026057 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/026057
AUTOPHAGY ACTIVATOR Sep 16, 2021 Pending
Array ( [id] => 18752404 [patent_doc_number] => 20230355646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => AUTOPHAGY ACTIVATOR [patent_app_type] => utility [patent_app_number] => 18/026057 [patent_app_country] => US [patent_app_date] => 2021-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16821 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18026057 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/026057
AUTOPHAGY ACTIVATOR Sep 16, 2021 Pending
Array ( [id] => 19135582 [patent_doc_number] => 11970512 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-30 [patent_title] => Amphotericin B derivatives with improved therapeutic index [patent_app_type] => utility [patent_app_number] => 17/464916 [patent_app_country] => US [patent_app_date] => 2021-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 46 [patent_no_of_words] => 16424 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17464916 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/464916
Amphotericin B derivatives with improved therapeutic index Sep 1, 2021 Issued
Array ( [id] => 18709100 [patent_doc_number] => 20230331692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => TRISULFIDE COMPOUND AND CLATHRATE THEREOF [patent_app_type] => utility [patent_app_number] => 18/042693 [patent_app_country] => US [patent_app_date] => 2021-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7449 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042693 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/042693
TRISULFIDE COMPOUND AND CLATHRATE THEREOF Aug 24, 2021 Pending
Array ( [id] => 18709100 [patent_doc_number] => 20230331692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => TRISULFIDE COMPOUND AND CLATHRATE THEREOF [patent_app_type] => utility [patent_app_number] => 18/042693 [patent_app_country] => US [patent_app_date] => 2021-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7449 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042693 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/042693
TRISULFIDE COMPOUND AND CLATHRATE THEREOF Aug 24, 2021 Pending
Array ( [id] => 18709100 [patent_doc_number] => 20230331692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => TRISULFIDE COMPOUND AND CLATHRATE THEREOF [patent_app_type] => utility [patent_app_number] => 18/042693 [patent_app_country] => US [patent_app_date] => 2021-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7449 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042693 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/042693
TRISULFIDE COMPOUND AND CLATHRATE THEREOF Aug 24, 2021 Pending
Array ( [id] => 18628184 [patent_doc_number] => 20230287032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => SYNTHESIS OF FLUORINATED NUCLEOTIDES [patent_app_type] => utility [patent_app_number] => 18/040679 [patent_app_country] => US [patent_app_date] => 2021-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12540 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040679 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/040679
SYNTHESIS OF FLUORINATED NUCLEOTIDES Aug 10, 2021 Pending
Array ( [id] => 17503429 [patent_doc_number] => 20220096531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => EYE DROP FORMULATION WITH ENHANCED PROPERTIES BY COMBINING SODIUM HYALURONATE WITH CARBOXYMETHYLCELLULOSE [patent_app_type] => utility [patent_app_number] => 17/399504 [patent_app_country] => US [patent_app_date] => 2021-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6532 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17399504 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/399504
EYE DROP FORMULATION WITH ENHANCED PROPERTIES BY COMBINING SODIUM HYALURONATE WITH CARBOXYMETHYLCELLULOSE Aug 10, 2021 Abandoned
Array ( [id] => 17368134 [patent_doc_number] => 20220023186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => DERMAL FILLER COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/396597 [patent_app_country] => US [patent_app_date] => 2021-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18646 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17396597 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/396597
DERMAL FILLER COMPOSITIONS Aug 5, 2021 Abandoned
Array ( [id] => 17226389 [patent_doc_number] => 20210352945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF [patent_app_type] => utility [patent_app_number] => 17/444063 [patent_app_country] => US [patent_app_date] => 2021-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43369 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17444063 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/444063
OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF Jul 29, 2021 Abandoned
Array ( [id] => 17168623 [patent_doc_number] => 20210322293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => GUAR HYDROXYPROPYLTRIMETHYLAMMONIUM CHLORIDE AND USES THEREOF IN HAIR TREATMENT COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/348354 [patent_app_country] => US [patent_app_date] => 2021-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14325 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348354 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/348354
GUAR HYDROXYPROPYLTRIMETHYLAMMONIUM CHLORIDE AND USES THEREOF IN HAIR TREATMENT COMPOSITIONS Jun 14, 2021 Pending
Array ( [id] => 17503403 [patent_doc_number] => 20220096505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/346475 [patent_app_country] => US [patent_app_date] => 2021-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16627 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17346475 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/346475
PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF Jun 13, 2021 Abandoned
Array ( [id] => 17368274 [patent_doc_number] => 20220023326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => ESTERS OF 2-DEOXY-MONOSACCHARIDES WITH ANTI PROLIFERATIVE ACTIVITY [patent_app_type] => utility [patent_app_number] => 17/339028 [patent_app_country] => US [patent_app_date] => 2021-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23526 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17339028 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/339028
Esters of 2-deoxy-monosaccharides with anti proliferative activity Jun 3, 2021 Issued
Array ( [id] => 18496113 [patent_doc_number] => 20230218657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => COMPOSITIONS, THEIR USES IN THERAPY AND METHODS THEREOF [patent_app_type] => utility [patent_app_number] => 18/000492 [patent_app_country] => US [patent_app_date] => 2021-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9036 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000492 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/000492
COMPOSITIONS, THEIR USES IN THERAPY AND METHODS THEREOF Jun 1, 2021 Pending
Array ( [id] => 18510003 [patent_doc_number] => 20230226098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-20 [patent_title] => ADHESION-PREVENTING AGENT AND METHOD FOR PREVENTING ADHESION USING SAME [patent_app_type] => utility [patent_app_number] => 18/007603 [patent_app_country] => US [patent_app_date] => 2021-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13712 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007603 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/007603
ADHESION-PREVENTING AGENT AND METHOD FOR PREVENTING ADHESION USING SAME May 31, 2021 Pending
Array ( [id] => 18510003 [patent_doc_number] => 20230226098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-20 [patent_title] => ADHESION-PREVENTING AGENT AND METHOD FOR PREVENTING ADHESION USING SAME [patent_app_type] => utility [patent_app_number] => 18/007603 [patent_app_country] => US [patent_app_date] => 2021-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13712 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007603 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/007603
ADHESION-PREVENTING AGENT AND METHOD FOR PREVENTING ADHESION USING SAME May 31, 2021 Pending
Menu